Eric M. Bonnem

Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects.

John A. Thompson, D J Lee, Pamela G. Kidd et al. · Journal of Clinical Oncology · 1989 · 177 citations

Hematological Malignancy, Myelodysplastic Syndrome, Bone Marrow Failure +14

Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions – a phase I dose-toxicity study

J.H. Scarffe, Robert D. Austin, Eric M. Bonnem et al. · British Journal of Cancer · 1989 · 85 citations · Full text

Inflammation, Daily Short Infusions, Granulocyte +7

Randomized Study of the Duration of Treatment With Interferon Alfa-2B in Patients With Hairy Cell Leukemia

Harvey M. Golomb, Mark J. Ratain, A Fefer et al. · JNCI Journal of the National Cancer Institute · 1988 · 77 citations

High-dose melphalan and granulocyte-macrophage colony-stimulating factor for refractory multiple myeloma

B Barlogie, S Jagannath, DO Dixon et al. · Blood · 1990 · 77 citations · Full text

Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.

Graham J. Lieschke, Dermot Maher, M O'Connor et al. · PubMed · 1990 · 68 citations

Immunology, Blood Cell, Pathology +20